| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 9.66e-15 | 14 | 134 | 8 | GO:0005130 | |
| GeneOntologyMolecularFunction | filamin binding | 1.88e-13 | 29 | 134 | 9 | GO:0031005 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.50e-12 | 23 | 134 | 8 | GO:0034235 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.27e-11 | 29 | 134 | 8 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.22e-11 | 34 | 134 | 8 | GO:0015125 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | PSG1 PSG2 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 STAP1 JUP PSG8 HSP90AA1 | 3.68e-10 | 149 | 134 | 12 | GO:1990782 |
| GeneOntologyMolecularFunction | glycolipid binding | 1.19e-09 | 49 | 134 | 8 | GO:0051861 | |
| GeneOntologyMolecularFunction | protein kinase binding | RAF1 PSG1 PSG2 PSG4 PSG5 NBEAL1 PSG6 PSG7 PSG9 PSG11 BACE1 DNM1L CNKSR2 STAP1 NOD2 RGS14 JUP PSG8 POTEJ MAPK7 IKBKB MAP2K6 HSP90AA1 | 1.77e-08 | 873 | 134 | 23 | GO:0019901 |
| GeneOntologyMolecularFunction | protein phosphatase binding | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 PPARG JUP PSG8 IKBKB HSP90AA1 | 1.83e-08 | 210 | 134 | 12 | GO:0019903 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.22e-08 | 70 | 134 | 8 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 3.10e-08 | 73 | 134 | 8 | GO:0170055 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYO1E PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 DAPK1 RYR1 PSG8 CNGA2 | 5.01e-08 | 230 | 134 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | kinase binding | RAF1 PSG1 PSG2 PSG4 PSG5 NBEAL1 PSG6 PSG7 PSG9 PSG11 BACE1 DNM1L CNKSR2 STAP1 NOD2 RGS14 JUP PSG8 POTEJ MAPK7 IKBKB MAP2K6 HSP90AA1 | 1.18e-07 | 969 | 134 | 23 | GO:0019900 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.63e-07 | 90 | 134 | 8 | GO:0008028 | |
| GeneOntologyMolecularFunction | phosphatase binding | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 PPARG JUP PSG8 IKBKB HSP90AA1 | 2.24e-07 | 264 | 134 | 12 | GO:0019902 |
| GeneOntologyMolecularFunction | lipid transporter activity | 8.38e-07 | 196 | 134 | 10 | GO:0005319 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.58e-06 | 173 | 134 | 9 | GO:0070851 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TMEM67 CTNNAL1 MYO1E PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 CEP57L1 APBB1 KIF4A DNM1L PPARG NOD2 CEP350 RGS14 CEP295 PSG8 HSP90AA1 | 3.91e-06 | 1099 | 134 | 22 | GO:0008092 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 9.57e-06 | 316 | 134 | 11 | GO:0035091 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.11e-05 | 207 | 134 | 9 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.15e-05 | 208 | 134 | 9 | GO:0005342 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 2.92e-05 | 293 | 134 | 10 | GO:0008514 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 3.45e-05 | 363 | 134 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activity | 4.64e-05 | 30 | 134 | 4 | GO:0004693 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein kinase activity | 4.64e-05 | 30 | 134 | 4 | GO:0097472 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 6.80e-05 | 324 | 134 | 10 | GO:0005126 | |
| GeneOntologyMolecularFunction | actin binding | CTNNAL1 MYO1E PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 NOD2 PSG8 | 9.46e-05 | 479 | 134 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | protein homodimerization activity | RBM44 PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 DNM1L JUP TRIM9 HOGA1 PSG8 IKBKB HSP90AA1 | 1.16e-04 | 815 | 134 | 16 | GO:0042803 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 2.14e-04 | 446 | 134 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | phospholipid binding | MYO1E PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 STAP1 PSG8 GGA1 VPS13B | 3.27e-04 | 548 | 134 | 12 | GO:0005543 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 1.48e-03 | 398 | 134 | 9 | GO:0046982 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | PSG1 PSG2 PSG4 PSG5 ABCA13 PSG6 PSG9 PSG11 SLC35E1 SLC25A16 PKDREJ RYR1 SLC41A2 ABCA6 SLC25A10 PSG8 CNGA2 | 2.36e-03 | 1180 | 134 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | protein kinase activity | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 2.41e-03 | 600 | 134 | 11 | GO:0004672 |
| GeneOntologyMolecularFunction | lipid binding | MYO1E PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 DNM1L PPARG STAP1 PSG8 GGA1 VPS13B | 2.62e-03 | 988 | 134 | 15 | GO:0008289 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1E DYNC2H1 ABCA13 KIF4A DDX56 CHD3 UBA7 ABCA6 HELZ2 DDX4 HSP90AA1 | 2.88e-03 | 614 | 134 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 2.96e-03 | 441 | 134 | 9 | GO:0016887 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 7.93e-15 | 14 | 135 | 8 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.69e-14 | 15 | 135 | 8 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.69e-14 | 15 | 135 | 8 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.69e-14 | 15 | 135 | 8 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.69e-14 | 15 | 135 | 8 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 3.36e-14 | 16 | 135 | 8 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.32e-14 | 17 | 135 | 8 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.32e-14 | 17 | 135 | 8 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 6.32e-14 | 17 | 135 | 8 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.13e-13 | 18 | 135 | 8 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 3.22e-13 | 20 | 135 | 8 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 4.15e-13 | 32 | 135 | 9 | GO:0045779 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 4.34e-13 | 47 | 135 | 10 | GO:0034104 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 5.17e-13 | 21 | 135 | 8 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 5.17e-13 | 21 | 135 | 8 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 5.17e-13 | 21 | 135 | 8 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 7.68e-13 | 34 | 135 | 9 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 8.08e-13 | 22 | 135 | 8 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.23e-12 | 23 | 135 | 8 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.23e-12 | 23 | 135 | 8 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.84e-12 | 24 | 135 | 8 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.84e-12 | 24 | 135 | 8 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.84e-12 | 24 | 135 | 8 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 2.69e-12 | 25 | 135 | 8 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 2.69e-12 | 25 | 135 | 8 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 5.46e-12 | 27 | 135 | 8 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 5.88e-12 | 60 | 135 | 10 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 7.60e-12 | 28 | 135 | 8 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.04e-11 | 29 | 135 | 8 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.90e-11 | 31 | 135 | 8 | GO:0010544 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.52e-11 | 32 | 135 | 8 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.52e-11 | 32 | 135 | 8 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 2.93e-11 | 70 | 135 | 10 | GO:0045124 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.30e-11 | 33 | 135 | 8 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.30e-11 | 33 | 135 | 8 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.36e-11 | 50 | 135 | 9 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.30e-11 | 34 | 135 | 8 | GO:0043116 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.54e-11 | 35 | 135 | 8 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.13e-10 | 38 | 135 | 8 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 1.15e-10 | 80 | 135 | 10 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.42e-10 | 39 | 135 | 8 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.60e-10 | 59 | 135 | 9 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.76e-10 | 40 | 135 | 8 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.18e-10 | 41 | 135 | 8 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.67e-10 | 42 | 135 | 8 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 4.80e-10 | 45 | 135 | 8 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 5.22e-10 | 67 | 135 | 9 | GO:0045601 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 5.78e-10 | 46 | 135 | 8 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 5.78e-10 | 46 | 135 | 8 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 6.85e-10 | 69 | 135 | 9 | GO:0030195 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 6.93e-10 | 47 | 135 | 8 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 6.93e-10 | 47 | 135 | 8 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 7.81e-10 | 70 | 135 | 9 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 7.94e-10 | 128 | 135 | 11 | GO:0034103 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 8.90e-10 | 71 | 135 | 9 | GO:0002347 | |
| GeneOntologyBiologicalProcess | bone resorption | 9.79e-10 | 99 | 135 | 10 | GO:0045453 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 9.83e-10 | 49 | 135 | 8 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 9.83e-10 | 49 | 135 | 8 | GO:0002837 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.01e-09 | 72 | 135 | 9 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 1.30e-09 | 134 | 135 | 11 | GO:0019217 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.61e-09 | 52 | 135 | 8 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.89e-09 | 53 | 135 | 8 | GO:0034110 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.98e-09 | 56 | 135 | 8 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 3.68e-09 | 83 | 135 | 9 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 3.94e-09 | 114 | 135 | 10 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 4.55e-09 | 85 | 135 | 9 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 4.55e-09 | 85 | 135 | 9 | GO:1903670 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 5.25e-09 | 60 | 135 | 8 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 6.01e-09 | 61 | 135 | 8 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 8.39e-09 | 91 | 135 | 9 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 1.02e-08 | 93 | 135 | 9 | GO:1900046 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.13e-08 | 127 | 135 | 10 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.14e-08 | 66 | 135 | 8 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.35e-08 | 96 | 135 | 9 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 1.35e-08 | 96 | 135 | 9 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 1.62e-08 | 98 | 135 | 9 | GO:0061045 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 2.06e-08 | 71 | 135 | 8 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 2.30e-08 | 72 | 135 | 8 | GO:0032692 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 2.57e-08 | 73 | 135 | 8 | GO:0042304 | |
| GeneOntologyBiologicalProcess | lipid localization | RELCH ACACB PSG1 PSG2 AUP1 PSG4 PSG5 ABCA13 PSG6 PSG9 PSG11 PPARG ABCA6 SLC25A10 PSG8 MAP2K6 VPS53 VPS13B | 3.13e-08 | 565 | 135 | 18 | GO:0010876 |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 3.51e-08 | 107 | 135 | 9 | GO:0042130 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 3.54e-08 | 76 | 135 | 8 | GO:0042269 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 3.76e-08 | 144 | 135 | 10 | GO:0097009 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 4.02e-08 | 145 | 135 | 10 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 4.77e-08 | 189 | 135 | 11 | GO:0010565 | |
| GeneOntologyBiologicalProcess | negative regulation of small molecule metabolic process | 5.20e-08 | 149 | 135 | 10 | GO:0062014 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 5.33e-08 | 80 | 135 | 8 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 5.91e-08 | 151 | 135 | 10 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 5.91e-08 | 151 | 135 | 10 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte activation | PSG1 PSG2 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 NFKBID PPARG LRFN5 PSG8 | 6.12e-08 | 240 | 135 | 12 | GO:0002695 |
| GeneOntologyBiologicalProcess | regulation of MAP kinase activity | 6.23e-08 | 194 | 135 | 11 | GO:0043405 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 7.11e-08 | 116 | 135 | 9 | GO:0045670 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 8.24e-08 | 118 | 135 | 9 | GO:0001570 | |
| GeneOntologyBiologicalProcess | negative regulation of defense response | UACA PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 PPARG NOD2 LRFN5 SERPING1 PSG8 MAPK7 | 8.42e-08 | 353 | 135 | 14 | GO:0031348 |
| GeneOntologyBiologicalProcess | endothelial cell differentiation | 9.06e-08 | 158 | 135 | 10 | GO:0045446 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 9.44e-08 | 86 | 135 | 8 | GO:0042058 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 9.62e-08 | 159 | 135 | 10 | GO:1903707 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 1.03e-07 | 87 | 135 | 8 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | GTPBP4 PSG1 PSG2 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 NFKBID PSG8 MAPK7 | 1.04e-07 | 252 | 135 | 12 | GO:0022408 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.27e-07 | 124 | 135 | 9 | GO:0001910 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 3.21e-14 | 16 | 136 | 8 | GO:0070021 | |
| GeneOntologyCellularComponent | ciliary membrane | TMEM67 TMEM17 PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 PSG8 CNGA2 | 4.06e-11 | 98 | 136 | 11 | GO:0060170 |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 CDK11A DAPK1 PSG8 CDK1 IKBKB | 4.80e-10 | 157 | 136 | 12 | GO:1902554 |
| GeneOntologyCellularComponent | protein kinase complex | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 CDK11A DAPK1 PSG8 CDK1 IKBKB | 1.20e-09 | 170 | 136 | 12 | GO:1902911 |
| GeneOntologyCellularComponent | lateral plasma membrane | 7.23e-09 | 90 | 136 | 9 | GO:0016328 | |
| GeneOntologyCellularComponent | adherens junction | 1.45e-07 | 212 | 136 | 11 | GO:0005912 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 CDK11A DAPK1 CRCP PSG8 CDK1 IKBKB | 3.01e-07 | 335 | 136 | 13 | GO:0061695 |
| GeneOntologyCellularComponent | T cell receptor complex | 1.16e-05 | 163 | 136 | 8 | GO:0042101 | |
| GeneOntologyCellularComponent | transferase complex | ZYG11A ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 CDK11A DAPK1 PPARG NAA25 CRCP PSG8 CDK1 POTEJ IKBKB NAA16 | 1.55e-05 | 963 | 136 | 19 | GO:1990234 |
| GeneOntologyCellularComponent | cell projection membrane | TMEM67 TMEM17 PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 PSG8 CNGA2 HSP90AA1 | 2.57e-05 | 431 | 136 | 12 | GO:0031253 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 4.76e-05 | 320 | 136 | 10 | GO:0016323 | |
| GeneOntologyCellularComponent | cilium | CDK20 CFAP47 TMEM67 TMEM17 PSG1 PSG2 PSG4 PSG5 DYNC2H1 PSG6 PSG9 PSG11 ACTL7A MROH2B PSG8 CNGA2 HSP90AA1 | 7.54e-05 | 898 | 136 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | basal plasma membrane | 1.10e-04 | 354 | 136 | 10 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 1.87e-04 | 378 | 136 | 10 | GO:0045178 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 4.84e-04 | 350 | 136 | 9 | GO:0098802 | |
| GeneOntologyCellularComponent | apical part of cell | MGAM PSG1 PSG2 PSG4 PSG5 DYNC2H1 PSG6 PSG9 PSG11 BTD PSG8 HSP90AA1 | 4.98e-04 | 592 | 136 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | 1.34e-03 | 487 | 136 | 10 | GO:0016324 | |
| GeneOntologyCellularComponent | receptor complex | 1.48e-03 | 581 | 136 | 11 | GO:0043235 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.69e-03 | 591 | 136 | 11 | GO:0005911 | |
| GeneOntologyCellularComponent | N-terminal protein acetyltransferase complex | 1.83e-03 | 10 | 136 | 2 | GO:0031414 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.13e-03 | 519 | 136 | 10 | GO:0009897 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.60e-13 | 17 | 110 | 8 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 2.12e-12 | 21 | 110 | 8 | MP:0031415 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 4.94e-12 | 35 | 110 | 9 | MP:0031618 | |
| MousePheno | decreased fatty acid oxidation | 7.52e-12 | 24 | 110 | 8 | MP:0014172 | |
| MousePheno | decreased muscle cell glucose uptake | 1.44e-11 | 39 | 110 | 9 | MP:0030022 | |
| MousePheno | increased abdominal fat pad weight | 2.23e-11 | 27 | 110 | 8 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.10e-11 | 28 | 110 | 8 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 7.71e-11 | 31 | 110 | 8 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 7.71e-11 | 31 | 110 | 8 | MP:0008964 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 8.81e-11 | 47 | 110 | 9 | MP:0031617 | |
| MousePheno | decreased cellular glucose uptake | 2.76e-10 | 53 | 110 | 9 | MP:0003926 | |
| MousePheno | abnormal muscle triglyceride level | 2.86e-10 | 36 | 110 | 8 | MP:0031412 | |
| MousePheno | abnormal fatty acid oxidation | 3.29e-10 | 54 | 110 | 9 | MP:0010953 | |
| MousePheno | polyphagia | 6.25e-10 | 80 | 110 | 10 | MP:0001433 | |
| MousePheno | abnormal lipid oxidation | 1.02e-09 | 61 | 110 | 9 | MP:0010951 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.59e-09 | 44 | 110 | 8 | MP:0031023 | |
| MousePheno | abnormal muscle cell glucose uptake | 2.43e-09 | 67 | 110 | 9 | MP:0004130 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 3.92e-09 | 49 | 110 | 8 | MP:0020948 | |
| MousePheno | decreased respiratory quotient | 1.46e-08 | 110 | 110 | 10 | MP:0010379 | |
| MousePheno | abnormal glycogen homeostasis | 1.68e-08 | 144 | 110 | 11 | MP:0005438 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 2.07e-08 | 60 | 110 | 8 | MP:0009790 | |
| MousePheno | increased insulin secretion | 3.49e-08 | 64 | 110 | 8 | MP:0003058 | |
| MousePheno | increased circulating leptin level | 5.01e-08 | 125 | 110 | 10 | MP:0005669 | |
| MousePheno | abnormal carbon dioxide production | 5.04e-08 | 67 | 110 | 8 | MP:0008962 | |
| MousePheno | abnormal vascular wound healing | 1.00e-07 | 73 | 110 | 8 | MP:0004883 | |
| MousePheno | abnormal cellular glucose uptake | 1.03e-07 | 102 | 110 | 9 | MP:0003925 | |
| MousePheno | abnormal respiratory quotient | 1.50e-07 | 178 | 110 | 11 | MP:0004129 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.57e-07 | 141 | 110 | 10 | MP:0004499 | |
| MousePheno | decreased oxygen consumption | 1.87e-07 | 79 | 110 | 8 | MP:0005290 | |
| MousePheno | decreased susceptibility to Riboviria infection | 2.50e-07 | 82 | 110 | 8 | MP:0020914 | |
| MousePheno | obese | 2.51e-07 | 113 | 110 | 9 | MP:0001261 | |
| MousePheno | increased food intake | 2.75e-07 | 189 | 110 | 11 | MP:0011939 | |
| MousePheno | abnormal oxygen consumption | 3.76e-07 | 195 | 110 | 11 | MP:0005288 | |
| MousePheno | decreased energy expenditure | 3.91e-07 | 119 | 110 | 9 | MP:0004890 | |
| MousePheno | abnormal energy expenditure | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 PPARG NCOR1 TLR5 AHSG PSG8 | 1.05e-06 | 313 | 110 | 13 | MP:0005450 |
| MousePheno | increased incidence of induced tumors | 1.05e-06 | 173 | 110 | 10 | MP:0002021 | |
| MousePheno | abnormal energy homeostasis | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 PPARG NCOR1 TLR5 AHSG PSG8 | 1.44e-06 | 322 | 110 | 13 | MP:0005448 |
| MousePheno | increased circulating insulin level | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 PPARG TLR5 PSG8 | 2.26e-06 | 283 | 110 | 12 | MP:0002079 |
| MousePheno | abnormal circulating leptin level | 2.47e-06 | 236 | 110 | 11 | MP:0005667 | |
| MousePheno | abnormal colon morphology | 3.06e-06 | 152 | 110 | 9 | MP:0000495 | |
| MousePheno | decreased triglyceride level | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 NFKBID PPARG HELZ2 AHSG PSG8 | 3.39e-06 | 348 | 110 | 13 | MP:0005318 |
| MousePheno | insulin resistance | 3.40e-06 | 197 | 110 | 10 | MP:0005331 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 4.60e-06 | 120 | 110 | 8 | MP:0009786 | |
| MousePheno | decreased susceptibility to viral infection | 6.24e-06 | 125 | 110 | 8 | MP:0002410 | |
| MousePheno | abnormal abdominal fat pad morphology | 6.73e-06 | 262 | 110 | 11 | MP:0000010 | |
| MousePheno | abnormal circulating insulin level | MGAM ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 PPARG TLR5 HELZ2 AHSG PSG8 | 9.44e-06 | 505 | 110 | 15 | MP:0001560 |
| MousePheno | decreased circulating triglyceride level | 1.06e-05 | 275 | 110 | 11 | MP:0002644 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.54e-05 | 286 | 110 | 11 | MP:0008873 | |
| MousePheno | increased body size | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 DNM1L RYR1 TLR5 PSG8 IKBKB | 1.92e-05 | 409 | 110 | 13 | MP:0001264 |
| MousePheno | abnormal food intake | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 PPARG RLN2 NCOR1 TLR5 PSG8 | 2.41e-05 | 481 | 110 | 14 | MP:0005449 |
| MousePheno | increased total tissue mass | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 RYR1 TLR5 PSG8 IKBKB | 2.88e-05 | 364 | 110 | 12 | MP:0012323 |
| MousePheno | increased body weight | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 RYR1 TLR5 PSG8 IKBKB | 2.88e-05 | 364 | 110 | 12 | MP:0001260 |
| MousePheno | abnormal fat pad morphology | 3.64e-05 | 314 | 110 | 11 | MP:0005334 | |
| MousePheno | abnormal incidence of induced tumors | 5.09e-05 | 269 | 110 | 10 | MP:0013151 | |
| MousePheno | abnormal insulin secretion | 6.04e-05 | 171 | 110 | 8 | MP:0003564 | |
| MousePheno | abnormal endocrine pancreas secretion | 7.40e-05 | 176 | 110 | 8 | MP:0014195 | |
| MousePheno | abnormal pancreas secretion | 9.73e-05 | 183 | 110 | 8 | MP:0002694 | |
| MousePheno | increased triglyceride level | 1.07e-04 | 354 | 110 | 11 | MP:0005317 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 1.09e-04 | 186 | 110 | 8 | MP:0020912 | |
| MousePheno | abnormal endocrine gland physiology | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 NFKBID NCOR1 PSG8 MAP2K6 | 1.33e-04 | 363 | 110 | 11 | MP:0013561 |
| MousePheno | abnormal wound healing | 1.41e-04 | 193 | 110 | 8 | MP:0005023 | |
| MousePheno | abnormal pancreatic beta cell physiology | 1.56e-04 | 196 | 110 | 8 | MP:0003562 | |
| MousePheno | decreased susceptibility to infection | 1.81e-04 | 255 | 110 | 9 | MP:0002409 | |
| MousePheno | abnormal endocrine pancreas physiology | 1.92e-04 | 202 | 110 | 8 | MP:0010147 | |
| MousePheno | abnormal circulating triglyceride level | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 NFKBID PPARG TLR5 AHSG PSG8 | 2.04e-04 | 516 | 110 | 13 | MP:0011969 |
| MousePheno | abnormal physiological response to xenobiotic | UACA PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SLC35E1 KIF4A PPARG RYR1 NOD2 TLR5 PSG8 | 2.07e-04 | 662 | 110 | 15 | MP:0008872 |
| MousePheno | abnormal gas homeostasis | PDS5B ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 RYR1 NCOR1 HELZ2 PSG8 | 2.54e-04 | 600 | 110 | 14 | MP:0003948 |
| MousePheno | abnormal eating behavior | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 PPARG RLN2 NCOR1 TLR5 PSG8 | 2.71e-04 | 604 | 110 | 14 | MP:0001431 |
| MousePheno | abnormal large intestine morphology | 3.26e-04 | 276 | 110 | 9 | MP:0000489 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 3.53e-04 | 279 | 110 | 9 | MP:0009785 | |
| MousePheno | abnormal susceptibility to viral infection | 3.53e-04 | 279 | 110 | 9 | MP:0020185 | |
| MousePheno | abnormal muscle morphology | RAF1 ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 BACE1 DNM1L MOSPD3 PPARG RYR1 JUP PTPRB AHSG PSG8 MAPK7 | 3.57e-04 | 1106 | 110 | 20 | MP:0002108 |
| MousePheno | abnormal triglyceride level | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 NFKBID PPARG TLR5 HELZ2 AHSG PSG8 | 4.79e-04 | 639 | 110 | 14 | MP:0000187 |
| MousePheno | abnormal pancreas physiology | 4.92e-04 | 292 | 110 | 9 | MP:0002693 | |
| MousePheno | increased total body fat amount | 5.05e-04 | 424 | 110 | 11 | MP:0010024 | |
| MousePheno | atrioventricular septal defect | 5.19e-04 | 84 | 110 | 5 | MP:0010412 | |
| MousePheno | increased circulating hormone level | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 PPARG TLR5 HELZ2 PSG8 | 6.04e-04 | 578 | 110 | 13 | MP:0014456 |
| MousePheno | abnormal atrioventricular septum morphology | 6.09e-04 | 87 | 110 | 5 | MP:0010592 | |
| MousePheno | abnormal induced morbidity/mortality | RAF1 PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 KIF4A PPARG RYR1 NOD2 SCUBE1 TLR5 PSG8 | 6.43e-04 | 737 | 110 | 15 | MP:0001657 |
| MousePheno | abnormal skeletal muscle morphology | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 BACE1 RYR1 PSG8 | 6.45e-04 | 508 | 110 | 12 | MP:0000759 |
| MousePheno | abnormal response to injury | RAF1 UACA PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 DAPK1 COLGALT2 PPARG PSG8 | 9.50e-04 | 607 | 110 | 13 | MP:0005164 |
| MousePheno | retina fold | 9.61e-04 | 25 | 110 | 3 | MP:0021107 | |
| MousePheno | abnormal consumption behavior | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 PPARG RLN2 NCOR1 TLR5 PSG8 | 1.09e-03 | 695 | 110 | 14 | MP:0002069 |
| MousePheno | ventricular hypoplasia | 1.09e-03 | 99 | 110 | 5 | MP:0000279 | |
| MousePheno | abnormal muscle physiology | RAF1 PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 SYNE1 BACE1 DNM1L PPARG RYR1 JUP PTCHD1 BTD PSG8 | 1.22e-03 | 954 | 110 | 17 | MP:0002106 |
| MousePheno | enhanced long-term object recognition memory | 1.26e-03 | 7 | 110 | 2 | MP:0014368 | |
| MousePheno | impaired glucose tolerance | PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 CNKSR2 PPARG PSG8 VPS13B | 1.39e-03 | 480 | 110 | 11 | MP:0005293 |
| MousePheno | abnormal embryonic neuroepithelium morphology | 1.42e-03 | 105 | 110 | 5 | MP:0004261 | |
| MousePheno | increased hormone level | ACACB PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 IAPP PSG11 PPARG TLR5 HELZ2 PSG8 | 1.55e-03 | 641 | 110 | 13 | MP:0014454 |
| MousePheno | increased lean body mass | 1.90e-03 | 354 | 110 | 9 | MP:0003960 | |
| MousePheno | abnormal muscle fiber mitochondrial morphology | 2.18e-03 | 33 | 110 | 3 | MP:0014342 | |
| Domain | Ig_2 | 2.88e-09 | 73 | 136 | 9 | PF13895 | |
| Domain | - | PDS5B ZYG11A RELCH INTS7 WDFY4 PPP4R4 JUP MRO MROH2B PDS5A TNPO3 | 6.93e-07 | 222 | 136 | 11 | 1.25.10.10 |
| Domain | ARM-like | PDS5B ZYG11A RELCH INTS7 WDFY4 PPP4R4 JUP MRO MROH2B PDS5A TNPO3 | 4.64e-06 | 270 | 136 | 11 | IPR011989 |
| Domain | ARM-type_fold | PDS5B ZYG11A RELCH INTS7 NBEAL1 WDFY4 PPP4R4 JUP MRO MROH2B PDS5A TNPO3 | 7.13e-06 | 339 | 136 | 12 | IPR016024 |
| Domain | V-set | 8.22e-06 | 184 | 136 | 9 | PF07686 | |
| Domain | IGc2 | 8.75e-06 | 235 | 136 | 10 | SM00408 | |
| Domain | Ig_sub2 | 8.75e-06 | 235 | 136 | 10 | IPR003598 | |
| Domain | ig | 1.06e-05 | 190 | 136 | 9 | PF00047 | |
| Domain | Immunoglobulin | 1.06e-05 | 190 | 136 | 9 | IPR013151 | |
| Domain | HEAT_REPEAT | 1.19e-05 | 70 | 136 | 6 | PS50077 | |
| Domain | Ig_V-set | 1.54e-05 | 199 | 136 | 9 | IPR013106 | |
| Domain | Ser/Thr_kinase_AS | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 6.18e-05 | 357 | 136 | 11 | IPR008271 |
| Domain | S_TKc | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 6.49e-05 | 359 | 136 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 6.99e-05 | 362 | 136 | 11 | PS00108 |
| Domain | Pkinase | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 1.10e-04 | 381 | 136 | 11 | PF00069 |
| Domain | - | PSG1 PSG2 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 PTPRB TRIM9 LRFN5 PSG8 ANKFN1 | 3.46e-04 | 663 | 136 | 14 | 2.60.40.10 |
| Domain | PROTEIN_KINASE_ATP | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 5.42e-04 | 459 | 136 | 11 | PS00107 |
| Domain | Ig-like_fold | PSG1 PSG2 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 PTPRB TRIM9 LRFN5 PSG8 ANKFN1 | 6.45e-04 | 706 | 136 | 14 | IPR013783 |
| Domain | RBD | 7.75e-04 | 6 | 136 | 2 | PF02196 | |
| Domain | Prot_kinase_dom | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 9.11e-04 | 489 | 136 | 11 | IPR000719 |
| Domain | IG_LIKE | PSG1 PSG2 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 LRFN5 PSG8 | 9.42e-04 | 491 | 136 | 11 | PS50835 |
| Domain | PROTEIN_KINASE_DOM | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 9.74e-04 | 493 | 136 | 11 | PS50011 |
| Domain | IG | 1.04e-03 | 421 | 136 | 10 | SM00409 | |
| Domain | Ig_sub | 1.04e-03 | 421 | 136 | 10 | IPR003599 | |
| Domain | RBD | 1.08e-03 | 7 | 136 | 2 | SM00455 | |
| Domain | RBD_dom | 1.08e-03 | 7 | 136 | 2 | IPR003116 | |
| Domain | RBD | 1.08e-03 | 7 | 136 | 2 | PS50898 | |
| Domain | Ig-like_dom | PSG1 PSG2 PSG4 PSG5 PSG6 PSG7 HLA-DQA1 PSG9 PSG11 LRFN5 PSG8 | 1.14e-03 | 503 | 136 | 11 | IPR007110 |
| Domain | - | 1.43e-03 | 8 | 136 | 2 | 2.60.40.360 | |
| Domain | PH-BEACH_dom | 1.43e-03 | 8 | 136 | 2 | IPR023362 | |
| Domain | - | 1.43e-03 | 8 | 136 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.43e-03 | 8 | 136 | 2 | PS51783 | |
| Domain | BEACH | 1.83e-03 | 9 | 136 | 2 | PS50197 | |
| Domain | Beach | 1.83e-03 | 9 | 136 | 2 | PF02138 | |
| Domain | - | 1.83e-03 | 9 | 136 | 2 | 1.10.1540.10 | |
| Domain | PapD-like | 1.83e-03 | 9 | 136 | 2 | IPR008962 | |
| Domain | Beach | 1.83e-03 | 9 | 136 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.83e-03 | 9 | 136 | 2 | IPR000409 | |
| Domain | Protein_kinase_ATP_BS | 1.85e-03 | 379 | 136 | 9 | IPR017441 | |
| Domain | Kinase-like_dom | CDK20 RAF1 CDKL2 STK17A CDK11A DAPK1 TTK CDK1 MAPK7 IKBKB MAP2K6 | 2.07e-03 | 542 | 136 | 11 | IPR011009 |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 3.27e-07 | 99 | 95 | 8 | MM14624 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 5.30e-07 | 188 | 95 | 10 | MM15828 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | RAF1 MGAM PSG1 PSG2 PSG4 PSG5 ABCA13 PSG6 PSG9 PSG11 NOD2 JUP PTPRB AHSG SERPING1 C2 PSG8 MAPK7 IKBKB MAP2K6 HSP90AA1 | 2.17e-06 | 995 | 95 | 21 | MM14661 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 6.23e-06 | 194 | 95 | 9 | M16312 | |
| Pathway | REACTOME_NEUTROPHIL_DEGRANULATION | MGAM PSG1 PSG2 PSG4 PSG5 ABCA13 PSG6 PSG9 PSG11 JUP PTPRB AHSG PSG8 HSP90AA1 | 7.80e-06 | 511 | 95 | 14 | MM15330 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 9.13e-06 | 258 | 95 | 10 | MM14572 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.11e-05 | 158 | 95 | 8 | MM14812 | |
| Pathway | WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ | 6.24e-05 | 12 | 95 | 3 | M39552 | |
| Pubmed | 2.09e-18 | 16 | 138 | 9 | 23123061 | ||
| Pubmed | Characterization of cDNA encoding novel pregnancy-specific glycoprotein variants. | 1.33e-17 | 7 | 138 | 7 | 7794280 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.33e-17 | 13 | 138 | 8 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.33e-17 | 13 | 138 | 8 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.33e-17 | 13 | 138 | 8 | 16638824 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 20044046 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 32150576 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 6265583 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.33e-17 | 13 | 138 | 8 | 12832451 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.33e-17 | 13 | 138 | 8 | 21670291 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 22162753 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 2702644 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 8380065 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 1279194 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 25724769 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.33e-17 | 13 | 138 | 8 | 22092845 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 11801635 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.33e-17 | 13 | 138 | 8 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.33e-17 | 13 | 138 | 8 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.33e-17 | 13 | 138 | 8 | 23800882 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 19285068 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 21760897 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.33e-17 | 13 | 138 | 8 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.33e-17 | 13 | 138 | 8 | 39168268 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 8402684 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 16619040 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.33e-17 | 13 | 138 | 8 | 8209741 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.33e-17 | 13 | 138 | 8 | 21949477 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 26219866 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 2133556 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 32521208 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 19406938 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.33e-17 | 13 | 138 | 8 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.33e-17 | 13 | 138 | 8 | 19358828 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 16680193 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.33e-17 | 13 | 138 | 8 | 34058224 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 10964771 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 32169849 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.33e-17 | 13 | 138 | 8 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.33e-17 | 13 | 138 | 8 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.33e-17 | 13 | 138 | 8 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.33e-17 | 13 | 138 | 8 | 23935487 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 15331748 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.33e-17 | 13 | 138 | 8 | 22406619 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.33e-17 | 13 | 138 | 8 | 25972571 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 19008452 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.33e-17 | 13 | 138 | 8 | 15220458 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 18843289 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 15207636 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 21081647 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 11133662 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 11483763 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 2164599 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 29396368 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 18003729 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.33e-17 | 13 | 138 | 8 | 33352461 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 38381498 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 20739537 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.33e-17 | 13 | 138 | 8 | 27695943 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 20404914 | ||
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.33e-17 | 13 | 138 | 8 | 32027621 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.33e-17 | 13 | 138 | 8 | 27777319 | |
| Pubmed | 6.33e-17 | 13 | 138 | 8 | 18848945 | ||
| Pubmed | 1.06e-16 | 8 | 138 | 7 | 1690992 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.47e-16 | 14 | 138 | 8 | 34666041 | |
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.47e-16 | 14 | 138 | 8 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.47e-16 | 14 | 138 | 8 | 32209360 | |
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 11994468 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 11850617 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 1.47e-16 | 14 | 138 | 8 | 26196244 | |
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 8896983 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 22962327 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 17623671 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.47e-16 | 14 | 138 | 8 | 18794798 | |
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 23469261 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 18454175 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 22159884 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 29907459 | ||
| Pubmed | 1.47e-16 | 14 | 138 | 8 | 36719377 | ||
| Interaction | PSG1 interactions | 4.93e-08 | 51 | 136 | 7 | int:PSG1 | |
| Interaction | PSG4 interactions | 1.36e-07 | 8 | 136 | 4 | int:PSG4 | |
| Cytoband | 19q13.2 | 4.00e-08 | 164 | 138 | 8 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | PSG1 PSG2 PSG4 PSG5 PSG6 PSG7 PSG9 PSG11 NFKBID RYR1 SCAF1 PSG8 GARRE1 ZNF583 | 1.56e-05 | 1192 | 138 | 14 | chr19q13 |
| Cytoband | 3p25 | 1.75e-05 | 17 | 138 | 3 | 3p25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr22q13 | 5.11e-04 | 330 | 138 | 6 | chr22q13 | |
| Cytoband | 17q24.3 | 1.18e-03 | 17 | 138 | 2 | 17q24.3 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.53e-20 | 11 | 91 | 9 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.66e-06 | 163 | 91 | 8 | 590 | |
| GeneFamily | Cyclin dependent kinases | 8.25e-06 | 26 | 91 | 4 | 496 | |
| GeneFamily | Ankyrin repeat domain containing | 2.20e-04 | 242 | 91 | 7 | 403 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 2.48e-04 | 5 | 91 | 2 | 1021 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 8.82e-04 | 9 | 91 | 2 | 1230 | |
| GeneFamily | Maestro heat like repeat containing | 1.34e-03 | 11 | 91 | 2 | 636 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 1.60e-03 | 12 | 91 | 2 | 660 | |
| GeneFamily | ATP binding cassette subfamily A | 2.19e-03 | 14 | 91 | 2 | 805 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.29e-12 | 32 | 137 | 8 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 9.47e-12 | 35 | 137 | 8 | MM757 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.43e-10 | 48 | 137 | 8 | MM531 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 8.11e-10 | 87 | 137 | 9 | MM851 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.48e-09 | 93 | 137 | 9 | M40279 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 2.47e-09 | 135 | 137 | 10 | MM965 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 5.70e-09 | 75 | 137 | 8 | MM605 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 3.75e-08 | 230 | 137 | 11 | MM986 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | C6orf62 PSG1 PSG2 PSG4 PSG5 PSG6 PSG9 PSG11 ACO2 CDK11A C1orf74 CEMIP2 CEP350 SCAF1 PSG8 GGA1 | 5.06e-08 | 568 | 137 | 16 | MM3824 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 6.59e-08 | 143 | 137 | 9 | MM989 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.64e-07 | 159 | 137 | 9 | MM760 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 2.46e-07 | 219 | 137 | 10 | MM3826 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 3.03e-07 | 224 | 137 | 10 | M40145 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 3.83e-07 | 128 | 137 | 8 | MM1000 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 5.14e-07 | 182 | 137 | 9 | MM993 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 1.18e-06 | 201 | 137 | 9 | MM1006 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | PSG1 PSG2 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 IAPP PSG11 PKDREJ RYR1 SCUBE1 SLC25A10 PDS5A PSG8 UQCRB | 1.75e-06 | 741 | 137 | 16 | MM1037 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 2.60e-06 | 284 | 137 | 10 | MM987 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP | 1.08e-05 | 200 | 137 | 8 | M8484 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 1.12e-05 | 201 | 137 | 8 | MM1294 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | RAF1 RELCH HLA-DQA1 DDX56 KDM5D ADCY7 UBA7 CRCP HELZ2 DENND6B TMEM131 IKBKB FUBP3 GARRE1 NAA16 ANKS1A | 2.14e-05 | 905 | 137 | 16 | M40865 |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 4.18e-05 | 177 | 137 | 7 | M39245 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | PSG1 PSG2 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 PKDREJ SCUBE1 SLC25A10 PSG8 UQCRB | 6.90e-05 | 689 | 137 | 13 | MM1041 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 8.57e-05 | 137 | 137 | 6 | M39241 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 8.75e-05 | 199 | 137 | 7 | M9124 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP | 9.03e-05 | 200 | 137 | 7 | M7856 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN | 9.03e-05 | 200 | 137 | 7 | M5216 | |
| Coexpression | GSE27786_LIN_NEG_VS_NKCELL_DN | 9.03e-05 | 200 | 137 | 7 | M4784 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | PSG1 PSG2 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 PPARG ADCY7 PSG8 | 1.19e-04 | 534 | 137 | 11 | MM1050 |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 1.67e-04 | 463 | 137 | 10 | MM1011 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING | PSG1 PSG2 AUP1 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 CEMIP2 CEP350 NCOR1 PSG8 GGA1 HSP90AA1 ANKS1A | 1.85e-04 | 1088 | 137 | 16 | MM3699 |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 1.96e-04 | 302 | 137 | 8 | MM16604 | |
| Coexpression | GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP | 2.00e-04 | 160 | 137 | 6 | M339 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 2.01e-04 | 102 | 137 | 5 | M10290 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 2.63e-04 | 490 | 137 | 10 | MM1001 | |
| Coexpression | MEBARKI_HCC_PROGENITOR_FZD8CRD_UP | ZYG11A PSG2 PSG5 PSG6 PSG9 CEP57L1 KIF4A CDCP1 TTK PPP4R4 CDK1 | 2.73e-04 | 588 | 137 | 11 | M38992 |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_DN | 2.78e-04 | 60 | 137 | 4 | M4856 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 2.87e-04 | 171 | 137 | 6 | M40134 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | PSG1 PSG2 PSG4 PSG5 PSG6 HLA-DQA1 PSG9 PSG11 SCUBE1 SLC25A10 PSG8 UQCRB | 2.95e-04 | 694 | 137 | 12 | MM1039 |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.08e-08 | 136 | 138 | 8 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.18e-06 | 190 | 138 | 7 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-06 | 191 | 138 | 7 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-06 | 153 | 138 | 6 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-06 | 157 | 138 | 6 | a9e077f686382303f0437ebfa4f11d273ba9fe40 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 166 | 138 | 6 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 166 | 138 | 6 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, Lineage and Cell Type | 1.37e-05 | 167 | 138 | 6 | 5b7b731944d888591279ef6167b3ae8cab3f6886 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-05 | 168 | 138 | 6 | 32e4d82efaccf336d347e4063253c3635a3ec672 | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 173 | 138 | 6 | 6e92983d9f8a2a37f23e60a0d5bb1738217897bc | |
| ToppCell | facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 173 | 138 | 6 | 4c788c1dad1da495b3b5c10f95e779848dfe85dc | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-05 | 176 | 138 | 6 | ac83a6cd4bcbb9ca1fc02a9fbd9d9629ef1df8ca | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.44e-05 | 185 | 138 | 6 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-05 | 111 | 138 | 5 | a1b7940c6fa0e5a58aa4798b604469d79f33fa44 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-05 | 111 | 138 | 5 | d1ec8e8e9adb11511b4ef363cc6f99286e2cc842 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-05 | 111 | 138 | 5 | 567e5ac2c78d45db207067f0f152bb24ed048c50 | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-05 | 111 | 138 | 5 | fd7aa25e83a0d762969e3966a658652da40c490e | |
| ToppCell | Thalamus-Hematopoietic-MACROPHAGE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.49e-05 | 111 | 138 | 5 | d48561078c387ac856c1c30e3d7a3e75ebde942e | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.52e-05 | 186 | 138 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 2.59e-05 | 187 | 138 | 6 | 4e64be635f445276e71f2937f33f041c3a4204ab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.67e-05 | 188 | 138 | 6 | d8decd9b5967873ca8320c2f9f07365f163c777f | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 2.75e-05 | 189 | 138 | 6 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-05 | 191 | 138 | 6 | ce0217d375af6b19252a45340b72241ea7b204d4 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 192 | 138 | 6 | c312e39003c51503c9f648332fb5c6218f33f99b | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Stem_cells|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.01e-05 | 192 | 138 | 6 | 1fc95f7e1a71683c8176693c79ee19eabae8b203 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 192 | 138 | 6 | df09056f0e562f53b6fb30b674d2d83e9eb857d0 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 192 | 138 | 6 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Stem_cells-Stem_cells|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.01e-05 | 192 | 138 | 6 | 378b994d8879512e2769760cfa900aebde90a3e2 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-05 | 192 | 138 | 6 | 133b3ad251d72ff31e45e1dc6217945516ac63de | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.01e-05 | 192 | 138 | 6 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 193 | 138 | 6 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.10e-05 | 193 | 138 | 6 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.19e-05 | 194 | 138 | 6 | b16ed97eb6b7b7a220e943474c0d85c141b6e3a5 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.19e-05 | 194 | 138 | 6 | 2210f0755882d8f04edb4c109fb17c3f9149f6f7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-05 | 194 | 138 | 6 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.28e-05 | 195 | 138 | 6 | 4cbc36fb3ef9aef61367d3b37070a9a85fae1418 | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 3.28e-05 | 195 | 138 | 6 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | Severe-B_naive-2|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.38e-05 | 196 | 138 | 6 | 19687c52c0e8e00c9fb3df2898ac32bec1dc30ee | |
| ToppCell | Healthy_donor-cDC|Healthy_donor / disease group, cell group and cell class (v2) | 3.47e-05 | 197 | 138 | 6 | b57a27e5b855bbdd1dfa352540599d260dc482aa | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 3.47e-05 | 197 | 138 | 6 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.47e-05 | 197 | 138 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.47e-05 | 197 | 138 | 6 | 8c24ffcd417da42fa9bcbe6bd0325360e537303f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-05 | 198 | 138 | 6 | 08ad0bece508bb4f9cc126d94839b5c89ce21ba8 | |
| ToppCell | Mild/Remission-B_naive-2|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.57e-05 | 198 | 138 | 6 | d238ad320e1989da01c48587f79eaeaa469cfa28 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.57e-05 | 198 | 138 | 6 | 80b105a7c7d00ea3b5e586831fbb755bd84f9d1a | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.57e-05 | 198 | 138 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-05 | 198 | 138 | 6 | c73e906d2d12d6eba0e606958be16e63a2292cd0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Intermediate|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 3.62e-05 | 120 | 138 | 5 | eb5b88c47dd4a6f9b55ace24f19d4e81d4ed31e1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 3.78e-05 | 200 | 138 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.78e-05 | 200 | 138 | 6 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 3.78e-05 | 200 | 138 | 6 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.63e-05 | 144 | 138 | 5 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 9.82e-05 | 148 | 138 | 5 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 152 | 138 | 5 | cefc0ab592e99badf145fb95adf9906cb81be81c | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 152 | 138 | 5 | c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-04 | 152 | 138 | 5 | c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.26e-04 | 156 | 138 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 156 | 138 | 5 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 161 | 138 | 5 | 16f77e7a5444d2f2b210362816cd7a07b9b42af6 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 161 | 138 | 5 | f5821f551cf5c64c9f75cdb723492c87aac1ece0 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 161 | 138 | 5 | 58a32a1033f379579697bda1bbf047a088e4a34f | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 1.46e-04 | 161 | 138 | 5 | a1f10e04836848b1deaf295fae033f54d1572fcd | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 162 | 138 | 5 | 388670cf3acef17df971c0d8ae3ce14398945192 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.50e-04 | 162 | 138 | 5 | 9333d923225df7bfdf6b3a4c32816751315aec50 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 163 | 138 | 5 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 163 | 138 | 5 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 163 | 138 | 5 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 167 | 138 | 5 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 167 | 138 | 5 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-04 | 168 | 138 | 5 | b7cd33f5da4f37b9384fc3bd3ca01fbc790accfc | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 168 | 138 | 5 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-STAT1+_Naive_B|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 168 | 138 | 5 | ba127d97697202a8558a0d50bcdafa30b0509de1 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | b46e446067c6425bd5b8ef7719aeecff5e861249 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 7a7416fcbffcf57d19b477d9da091e04e3499524 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 5508b03fbf483fce7701d6c82c297ffda3b1ba05 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 0e1a99cd77edcf32bcb513abd247b2b27409ac63 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 169 | 138 | 5 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 169 | 138 | 5 | 9bbad31ef03078f5aa456f2e1b17b49c91545ff0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 1.93e-04 | 171 | 138 | 5 | 976361f67dd725870e0513ae7a92f2dcaee17148 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 171 | 138 | 5 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 171 | 138 | 5 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 173 | 138 | 5 | d13ae4046a25ee0fb492ddedf44583a879a432e9 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 2a5ea28c65dd4ee03ba3d0bfe0c819b1d583f8da | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 173 | 138 | 5 | 6a7e4fa2d9d00f50decc89b535d8a68ec96de58a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 174 | 138 | 5 | ba909e8789a62968e90bc1c4ab614de738c130f7 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 174 | 138 | 5 | 9f7b983459d47b12a1b64e17e29b85a6ff4dc258 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 175 | 138 | 5 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-04 | 175 | 138 | 5 | 9142ed8ca2f1c0c518deb21988221406f62fe38c | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 175 | 138 | 5 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 175 | 138 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | metastatic_Brain-Myeloid_cells-Activated_DCs|metastatic_Brain / Location, Cell class and cell subclass | 2.26e-04 | 177 | 138 | 5 | 739496fcc4156f4d5e3de9cd21cf3856037f0678 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 178 | 138 | 5 | be1d991c5a0a5be22f14f57d34ee1330f1a12963 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 178 | 138 | 5 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 178 | 138 | 5 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.38e-04 | 179 | 138 | 5 | 021d782134126c6f7dce6b6ea50cc54bdaa39987 | |
| ToppCell | Control-Developping_Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.38e-04 | 179 | 138 | 5 | 9383568f78b07b8cca72ece5d15fea209aa54ea9 | |
| Computational | Neighborhood of EGFR | 4.31e-09 | 32 | 85 | 7 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 8.46e-09 | 35 | 85 | 7 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 3.25e-08 | 42 | 85 | 7 | GNF2_MMP11 | |
| Computational | Neighborhood of CDKN1C | 5.30e-08 | 27 | 85 | 6 | GNF2_CDKN1C | |
| Computational | Neighborhood of TIMP2 | 6.28e-08 | 46 | 85 | 7 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 9.88e-08 | 49 | 85 | 7 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 3.76e-12 | 43 | 137 | 9 | CID000004683 | |
| Drug | pP-8 | 2.56e-07 | 10 | 137 | 4 | CID000444681 | |
| Drug | Rgd Peptide | 1.93e-06 | 239 | 137 | 10 | CID000104802 | |
| Drug | Betaxolol hydrochloride [63659-19-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.12e-06 | 197 | 137 | 9 | 4608_DN | |
| Disease | cD177 antigen measurement | 5.45e-15 | 18 | 132 | 8 | EFO_0021866 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 1.73e-06 | 6 | 132 | 3 | EFO_0801907 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 3.02e-06 | 7 | 132 | 3 | EFO_0801906 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 1.99e-05 | 2 | 132 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 1.99e-05 | 2 | 132 | 2 | OBA_2043059 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 5.39e-05 | 215 | 132 | 7 | EFO_0008317, EFO_0008591 | |
| Disease | Indirect Hyperbilirubinemia, Neonatal | 5.94e-05 | 3 | 132 | 2 | C1565886 | |
| Disease | Direct Hyperbilirubinemia, Neonatal | 5.94e-05 | 3 | 132 | 2 | C1565885 | |
| Disease | Hyperbilirubinemia, Neonatal | 5.94e-05 | 3 | 132 | 2 | C0857007 | |
| Disease | pancreatic carcinoma (biomarker_via_orthology) | 5.94e-05 | 3 | 132 | 2 | DOID:4905 (biomarker_via_orthology) | |
| Disease | phospholipid measurement, intermediate density lipoprotein measurement | 8.48e-05 | 99 | 132 | 5 | EFO_0004639, EFO_0008595 | |
| Disease | ulcerative colitis, Crohn's disease | 9.44e-05 | 20 | 132 | 3 | EFO_0000384, EFO_0000729 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 1.18e-04 | 4 | 132 | 2 | EFO_0801909 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 1.86e-04 | 63 | 132 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | apolipoprotein B measurement | RAF1 ACACB PSG1 HLA-DQA1 BACE1 DDX56 MOSPD3 PPARG PPP4R4 ABCA6 MAP2K6 | 2.01e-04 | 663 | 132 | 11 | EFO_0004615 |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 2.95e-04 | 71 | 132 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | white matter integrity | 3.04e-04 | 130 | 132 | 5 | EFO_0004641 | |
| Disease | Malignant neoplasm of breast | RAF1 DYNC2H1 SYNE1 ACO2 COLGALT2 TRAPPC8 PKDREJ NCOR1 NAA25 IKBKB GGA1 CNGA2 VPS13B HSP90AA1 | 3.34e-04 | 1074 | 132 | 14 | C0006142 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.48e-04 | 291 | 132 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | CUB domain-containing protein 1 measurement | 4.11e-04 | 7 | 132 | 2 | EFO_0802432 | |
| Disease | hepatocyte growth factor receptor measurement | 4.11e-04 | 7 | 132 | 2 | EFO_0008153 | |
| Disease | smoking status measurement, inflammatory bowel disease | 4.11e-04 | 7 | 132 | 2 | EFO_0003767, EFO_0006527 | |
| Disease | Thyroid preparation use measurement | 4.48e-04 | 217 | 132 | 6 | EFO_0009933 | |
| Disease | stroke | 4.86e-04 | 144 | 132 | 5 | EFO_0000712 | |
| Disease | autoimmune disease (is_implicated_in) | 5.46e-04 | 8 | 132 | 2 | DOID:417 (is_implicated_in) | |
| Disease | Parkinson disease | 6.24e-04 | 321 | 132 | 7 | MONDO_0005180 | |
| Disease | hepatocellular carcinoma | 8.24e-04 | 41 | 132 | 3 | EFO_0000182 | |
| Disease | CCL19 measurement | 8.73e-04 | 10 | 132 | 2 | EFO_0009415 | |
| Disease | fibroblast growth factor 23 measurement | 9.47e-04 | 43 | 132 | 3 | EFO_0009381 | |
| Disease | mean reticulocyte volume | PDS5B ZYG11A PSG1 HLA-DQA1 STK17A MOSPD3 CNOT6 CEP350 GALNT9 HELZ2 PRXL2C | 9.54e-04 | 799 | 132 | 11 | EFO_0010701 |
| Disease | eosinophil count | GTPBP4 FKBP10 UACA PSG1 HLA-DQA1 ACO2 SLC35E1 STOX1 PPARG ADCY7 RGS14 NAA25 MRO HELZ2 TMEM131 ZC3H7B | 1.02e-03 | 1488 | 132 | 16 | EFO_0004842 |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 1.05e-03 | 171 | 132 | 5 | DOID:9352 (is_implicated_in) | |
| Disease | NG-monomethyl-arginine measurement | 1.06e-03 | 11 | 132 | 2 | EFO_0010510 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.06e-03 | 11 | 132 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | smoking status measurement, forced expiratory volume | 1.06e-03 | 11 | 132 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.24e-03 | 264 | 132 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 1.25e-03 | 104 | 132 | 4 | EFO_0008591, EFO_0008595 | |
| Disease | remnant cholesterol measurement | 1.43e-03 | 108 | 132 | 4 | EFO_0010815 | |
| Disease | neutrophil-to-lymphocyte ratio | 1.49e-03 | 185 | 132 | 5 | EFO_0008447 | |
| Disease | coronary artery disease, factor VII measurement | 1.58e-03 | 111 | 132 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | GDH/6PGL endoplasmic bifunctional protein measurement | 1.74e-03 | 14 | 132 | 2 | EFO_0801619 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 1.75e-03 | 114 | 132 | 4 | EFO_0004574, EFO_0004611 | |
| Disease | hypothyroidism | 1.79e-03 | 284 | 132 | 6 | EFO_0004705 | |
| Disease | factor XI measurement, coronary artery disease | 1.80e-03 | 115 | 132 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 2.11e-03 | 120 | 132 | 4 | EFO_0004611, EFO_0004639 | |
| Disease | neutrophil collagenase measurement | 2.29e-03 | 16 | 132 | 2 | EFO_0008248 | |
| Disease | Dermatitis | 2.29e-03 | 16 | 132 | 2 | C0011603 | |
| Disease | Sjogren syndrome | 2.49e-03 | 60 | 132 | 3 | EFO_0000699 | |
| Disease | cholesteryl ester measurement, low density lipoprotein cholesterol measurement | 2.51e-03 | 126 | 132 | 4 | EFO_0004611, EFO_0010351 | |
| Disease | bacterial pathogen genotype measurement, pulmonary tuberculosis | 2.58e-03 | 17 | 132 | 2 | EFO_0010271, EFO_1000049 | |
| Disease | urolithiasis | 2.86e-03 | 63 | 132 | 3 | MONDO_0024647 | |
| Disease | tropical spastic paraparesis | 2.90e-03 | 18 | 132 | 2 | EFO_0007527 | |
| Disease | Alzheimer's disease (is_implicated_in) | 2.97e-03 | 132 | 132 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | systemic lupus erythematosus | HLA-DQA1 CNKSR2 PPARG WDFY4 GALNT9 C2orf42 C2 IKBKB TNPO3 ANKS1A | 3.23e-03 | 799 | 132 | 10 | MONDO_0007915 |
| Disease | angiopoietin-1 receptor measurement | 3.23e-03 | 19 | 132 | 2 | EFO_0010600 | |
| Disease | visual perception measurement | 3.35e-03 | 223 | 132 | 5 | EFO_0009700 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 3.40e-03 | 137 | 132 | 4 | EFO_0004611, EFO_0008591 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 3.42e-03 | 224 | 132 | 5 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 3.48e-03 | 225 | 132 | 5 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.48e-03 | 225 | 132 | 5 | EFO_0008317, EFO_0020947 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 3.58e-03 | 20 | 132 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 3.75e-03 | 229 | 132 | 5 | EFO_0004639, EFO_0008317 | |
| Disease | metabolite measurement, diet measurement | 4.01e-03 | 71 | 132 | 3 | EFO_0004725, EFO_0008111 | |
| Disease | Lupus Erythematosus, Systemic | 4.01e-03 | 71 | 132 | 3 | C0024141 | |
| Disease | inflammatory bowel disease | 4.17e-03 | 449 | 132 | 7 | EFO_0003767 | |
| Disease | total blood protein measurement | 4.17e-03 | 449 | 132 | 7 | EFO_0004536 | |
| Disease | progranulin measurement | 4.33e-03 | 22 | 132 | 2 | EFO_0004625 | |
| Disease | progression free survival, ovarian serous carcinoma | 4.33e-03 | 22 | 132 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | ubiquitin carboxyl-terminal hydrolase 25 measurement | 4.33e-03 | 22 | 132 | 2 | EFO_0021881 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLIEINLSELKPHIN | 336 | Q99798 | |
| HITNILQVKQILDTP | 436 | Q9NWW7 | |
| LKNPLQVVLVATHAD | 876 | P53355 | |
| LVKQTHVPNLFSLQL | 201 | P56817 | |
| NNIVHRDLKPANLLI | 121 | Q8IZL9 | |
| HLAVKVANQASLPLV | 591 | Q8TDY4 | |
| SLELLQKDVVQLHAP | 81 | Q9GZU0 | |
| ELPSVLLLHQLAKQE | 91 | Q6Y288 | |
| LESDNHLAQPLVKVL | 646 | Q9NQI0 | |
| HLAQPLVKVLTDAQQ | 651 | Q9NQI0 | |
| HLKIFSPNVVNLTLV | 131 | O00429 | |
| LNLDPLITHTLNLDK | 341 | P28332 | |
| RLSLVLVPAQKLQQH | 456 | Q9H5V8 | |
| NKVNEVLNRLHLAIP | 351 | Q9BZE4 | |
| LVSAFKLHEQLNVPV | 1396 | Q8N139 | |
| QHPNNLLKTIETVLE | 2766 | Q86UQ4 | |
| KALVAEIITHLQGLQ | 136 | Q96LT6 | |
| LKLVEPQSQALLHAQ | 431 | O00213 | |
| EVVKMLLNAHPNLLS | 196 | Q92625 | |
| KRQQENLLLSVLPAH | 226 | P51828 | |
| PLDLLKVHLQTQQEV | 26 | Q9UBX3 | |
| HQLPVKEATLQRAQL | 551 | Q8NEG7 | |
| PQFALTNIAVLKHNL | 81 | P01909 | |
| DNPNVLVLKTHVNLL | 231 | P16260 | |
| LIKNLTHQIINTDPV | 1201 | Q6ZS30 | |
| QILSSIELLQHSLPK | 601 | P04049 | |
| IELLQHSLPKINRSA | 606 | P04049 | |
| IVENKILLHLENPST | 346 | Q6ZP01 | |
| LDTVLVNLVPAHKNL | 196 | Q9NTI5 | |
| LDSILINLIPAHKNL | 206 | Q29RF7 | |
| ALDLNLKHQILPKEQ | 66 | P14927 | |
| QLQQHVPVLKDSSLL | 111 | P04090 | |
| LAIQDLKLLANKTPH | 271 | Q9NVH2 | |
| HIKPNALLTNVDQIV | 696 | Q96NI6 | |
| AQQTLPILGEKLHQV | 981 | O00763 | |
| VIPHLHKLALVNNLQ | 1086 | Q9P260 | |
| AQVIHRDLKPSNLLV | 176 | Q13164 | |
| VPLAVLQLRVKHANE | 466 | P23467 | |
| QKLQHRLIEPNAAVT | 266 | Q86XE5 | |
| IIHRDLKPENIVLQQ | 141 | O14920 | |
| LTHLPENLDSLVNLK | 456 | A6NIV6 | |
| LHLAVQAANPTLVQL | 211 | Q8NI38 | |
| NHTPSQLLKEVILVD | 176 | Q9HCQ5 | |
| ELLNKQSVPAHFVAL | 606 | P06681 | |
| HNNGQKLVIIVDPAI | 441 | O43451 | |
| VHLPNIQALKEALTK | 1001 | Q9BY66 | |
| ILHNPVTLKLQESQL | 211 | Q9NY93 | |
| FQKAPAISVLHELIQ | 71 | P01562 | |
| IITLAQKLDQANHAP | 1611 | Q9NYQ8 | |
| IKRANIHLASLQPAE | 3661 | Q9NYQ8 | |
| LIPLKNLVADNIDTH | 661 | Q6N069 | |
| VRQIAAKIDSIPHLN | 26 | Q96I24 | |
| DSPAQLVMLKHLQVL | 301 | Q6UY01 | |
| KLLLPQQLQAEADHL | 206 | H0YM25 | |
| LATRLLAHKIQSPQE | 46 | Q9UJY5 | |
| SLLIHLQDRNPQVAK | 181 | Q9BYG7 | |
| KVPLINELESAIHQL | 461 | Q9Y5B6 | |
| LAEPSQLLKSAIVHL | 116 | P14923 | |
| IVLSVALNHLKATPI | 11 | P10997 | |
| NIIHRDIKPENILVS | 121 | Q92772 | |
| GQLLALTIQHEKPDL | 3401 | Q8NCM8 | |
| VLLIDVHNPKDAVQL | 256 | Q96AY3 | |
| LLPLVSQITTLINHK | 41 | Q9UBT7 | |
| LLAPLNDTRVVHAAK | 151 | P02765 | |
| PANAVLHKVLNQLEE | 1856 | Q12873 | |
| AVLALHDVLKQQLSL | 586 | Q9H6X5 | |
| QSAAIPEHQLKELNI | 261 | O15063 | |
| VPALHLLKELNATSR | 2226 | Q5VT06 | |
| HLIIAQVAKNPVGLI | 331 | P43251 | |
| LREINTILKAQHPNI | 471 | Q9UQ88 | |
| KQLNISHLLVPLGLA | 1296 | Q9UHN6 | |
| HNLSLVILVPQNLKH | 351 | P05155 | |
| IVNIDPQTAELNHLK | 341 | O95239 | |
| ILHSPNSQALILALK | 46 | Q8IYX8 | |
| LHINLIPNKQDRTLT | 76 | P07900 | |
| LKPHQTLQEDIENLI | 296 | Q8IYK4 | |
| SLHLAVQLKAQPLDK | 1726 | Q9BYK8 | |
| LANTTDQVKLEILPH | 321 | Q9Y3R0 | |
| LPLHDSLKLLQEQLT | 1051 | Q9C0D2 | |
| SEGKDVLLLVHNLPQ | 46 | Q00888 | |
| SEGKDVLLLVHNLPQ | 46 | Q9UQ72 | |
| KLIKALFDVLAHPQN | 941 | Q8IWY4 | |
| PEVLNIIQENHIKSI | 571 | P21817 | |
| VLDINRKSQLIISPH | 2686 | Q6ZTR5 | |
| PHLGTEKQLILVANA | 346 | Q9ULM6 | |
| QHILKNPLIINSIID | 36 | Q9UNQ2 | |
| SEGKDVLLLVHNLPQ | 46 | P11464 | |
| IHRDVKPSNVLINAL | 176 | P52564 | |
| LAVPVLNLNLQHNKI | 411 | Q5HYA8 | |
| EPSVQAHIKALLALL | 236 | P59551 | |
| AEKLQLLNHRPVTAV | 81 | O75575 | |
| HEILNPLVSKAQLSQ | 171 | Q6NUP7 | |
| LLTNIPAVQEKLHQL | 6891 | Q8NF91 | |
| SEGKDVLLLVHNLPQ | 46 | Q00889 | |
| LAPQHSLAKIERNLV | 56 | Q96NR3 | |
| DLRLNIIKSLHQNPV | 1171 | Q9NTG1 | |
| SEGKDVLLLVHNLPQ | 46 | Q9UQ74 | |
| SEGKDVLLLVHNLPQ | 46 | Q00887 | |
| PVVHEKQDSLLLLSQ | 2156 | O75376 | |
| LLQALELQLKLNHPE | 441 | P37231 | |
| DLQLSHNQLTKVPRI | 266 | O60938 | |
| LTPLLLGVHEQKQQV | 236 | P0CG39 | |
| NKSAQVLLLLVIPGH | 466 | Q96JW4 | |
| SEGKDVLLLVHNLPQ | 46 | Q13046 | |
| QQARKHLLPVTTADL | 341 | Q96K37 | |
| LKPQLSLQDHLNILE | 816 | Q7Z745 | |
| DVVHLDLKPQNILLT | 181 | Q9UEE5 | |
| ELNNTNVHLKLVNPL | 121 | Q9Y615 | |
| AVKALLQQINIPLHQ | 686 | Q8N957 | |
| KELRHPNIVSLQDVL | 56 | P06493 | |
| NLPAKLRAEIAINVH | 431 | Q16280 | |
| AHLEVIQLANIKPSE | 211 | Q8WXI2 | |
| QLATLAQRVKEVLPH | 296 | Q9Y679 | |
| NRLDHKPINSVLQLV | 196 | Q7RTV5 | |
| NEGLTNLPLEKAIHI | 131 | Q86X19 | |
| ALLQKAEPHNLQITA | 661 | Q9HC29 | |
| EKQAQHLPLRVTELV | 961 | P41226 | |
| ELIQATNQILSHRKP | 1126 | Q9H7N4 | |
| NPILTVDNLIKHTVL | 366 | Q6ZVD7 | |
| QNVSLLPGQVIKLHE | 126 | Q9ULZ2 | |
| TQDLPKVLNLHLLNS | 336 | Q92545 | |
| QLPQVLHVSLGQKLV | 206 | O75425 | |
| AEAAHQAQLIPKLIF | 1501 | Q6ZS81 | |
| LQLTLALIKPDAVAH | 11 | O75414 | |
| PLILEAVHQQILSNK | 26 | O75414 | |
| LQEALQPILEKHGLS | 396 | O43566 | |
| DVPLISLANILHNAK | 1051 | Q96AE7 | |
| VILHIKQNVPIIRDN | 641 | Q5VIR6 | |
| PLLQSIHQLDFVQVK | 421 | Q9C026 | |
| LAVQNLLQKQHVPLE | 1101 | Q9BZF9 | |
| LLQKQHVPLEQVEAL | 1106 | Q9BZF9 | |
| LTHIQNLKDLSPVIV | 91 | Q9Y5L0 | |
| QIINQISKLHAIIDP | 736 | P33981 | |
| QPVNLLVSIHASLKL | 3591 | Q7Z7G8 | |
| LPHIEKTIRQLNDQL | 361 | Q9Y2L5 | |
| SEGKDVLLLVHNLPQ | 46 | P11465 | |
| VTLPKINLTANLIHL | 416 | O60602 | |
| LHLQAAKLALLASIQ | 276 | Q9Y334 | |
| SEGKDVLLLVHNLPQ | 46 | Q15238 | |
| HLLQQKDILPNVVSL | 276 | Q6WRX3 | |
| QLIITHKEILPEVQN | 141 | Q96ND8 | |
| NTALLIKNPLAATHE | 406 | Q9UGR2 | |
| HVKDIILQSNPLLEA | 141 | Q12965 | |
| KLALPADIRALQQHL | 401 | Q14CX7 |